Clinical Trial Update: Rolipram to Treat Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Rolipram in multiple sclerosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Rolipram (rolipram)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED